Finanza

Discussioni Tecnici Stagionalità

Utile netto diluito per azionisti ordinari su HUBEI BIOCAUSE HEI.

Dati annuali

2019

2020

2021

2022

2023

TTM

‪0,00‬

‪‪50,00 M‬‬

‪‪100,00 M‬‬

‪‪150,00 M‬‬

‪‪200,00 M‬‬

Periodo

Valore

Variazione

Variazione %

TTM

‪‪106,26 M‬‬

‪‪−69,85 M‬‬

‪−39,66‬%

2023

‪‪176,12 M‬‬

+‪‪50,32 M‬‬

+‪40,00‬%

2022

‪‪125,79 M‬‬

+‪‪4,14 M‬‬

+‪3,41‬%

2021

‪‪121,65 M‬‬

‪‪−46,42 M‬‬

‪−27,62‬%

2020

‪‪168,07 M‬‬

+‪‪67,78 M‬‬

+‪67,59‬%

2019

‪‪100,29 M‬‬

+‪‪52,55 M‬‬

+‪110,09‬%

Dati trimestrali

Q1 '21

Q2 '21

Q3 '21

Q4 '21

Q1 '22

Q2 '22

Q3 '22

Q4 '22

Q1 '23

Q2 '23

Q3 '23

Q4 '23

Q1 '24

Q2 '24

Q3 '24

‪0,00‬

‪‪20,00 M‬‬

‪‪40,00 M‬‬

‪‪60,00 M‬‬

‪‪80,00 M‬‬

Periodo

Valore

Variazione

Variazione %

Q3 '24

‪‪6,17 M‬‬

‪‪−24,95 M‬‬

‪−80,18‬%

Q2 '24

‪‪31,11 M‬‬

‪‪−6,27 M‬‬

‪−16,77‬%

Q1 '24

‪‪37,38 M‬‬

+‪‪5,78 M‬‬

+‪18,29‬%

Q4 '23

‪‪31,60 M‬‬

+‪‪125,11 K‬‬

+‪0,40‬%

Q3 '23

‪‪31,48 M‬‬

‪‪−41,64 M‬‬

‪−56,95‬%

Q2 '23

‪‪73,12 M‬‬

+‪‪33,19 M‬‬

+‪83,14‬%

Q1 '23

‪‪39,92 M‬‬

‪‪−7,25 M‬‬

‪−15,37‬%

Q4 '22

‪‪47,17 M‬‬

+‪‪23,02 M‬‬

+‪95,31‬%

Q3 '22

Q2 '22

Q1 '22

Q4 '21

Q3 '21

Q2 '21

Q1 '21